Dronabinol Oral Solution

Dronabinol Oral Solution is an orally-administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a synthetic version of tetrahydrocannabinol (THC), which may offer advantages over Dronabinol SG, including more consistent bioavailability, faster onset of action and more flexible dose titration.

Drug Indication Preclinical Phase 1 Phase 2/3 NDA Approved
Fentanyl Sublingual Spray BTCP in Opioid Tolerant Patients
Dronabinol SG (Generic MarinolĀ®) 2nd Line CINV
Dronabinol Oral Solution 2nd Line CINV

We submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in August 2014 for Dronabinol Oral Solution for anorexia associated with weight loss in patients with AIDS; and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.